Biopsafe ApS: Financial statements 2021
CVR: 33575505
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Biopsafe ApS (CVR 33575505) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 7,541,402 and a net result of DKK 250,066 compared with DKK 219,043 the year before. That is an increase of 44.8% compared with the year before. Equity in the 2021 report amounted to DKK 4,250,346. The solvency ratio was 17.5%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 7,541,402
- Profit/Loss
- DKK 250,066
- Equity
- DKK 4,250,346
- Total Assets
- DKK 24,323,498
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 7.5 mio. | 250 t. | 4.3 mio. | 3 |
| 2020 | - | 5.2 mio. | 219 t. | 4 mio. | 3 |
| 2019 | - | 6.3 mio. | 268 t. | 3.8 mio. | 1 |
| 2018 | - | 4.6 mio. | 39 t. | 3.5 mio. | 1 |
| 2017 | - | 557 t. | -2.2 mio. | 436 t. | 1 |
Official annual report
Find more companies like Biopsafe ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
As of September 1, 2021, Taastrup 2024 P/S has been appointed auditor of Biopsafe ApS.
As of September 1, 2021, Grant Thornton, Godkendt Revisionspartnerselskab has stepped down as auditor of Biopsafe ApS.
Biopsafe ApS has published its annual report for 2020. Gross profit came to DKK 5,209,304, and the net result was DKK 219,043.
About Biopsafe ApS
Biopsafe ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2011. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named AX-LAB INNOVATION ApS. The management consists of Anne Lykke Gade. The board consists of Anders Dahlberg. The company is owned by MedCap AB (publ). The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 14,274,000 and a net result of DKK 6,231,000 compared with DKK 4,087,000 the year before. Equity in the 2025 report amounted to DKK 11,231,000.